Afamelanotide

1 study on Afamelanotide curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on Afamelanotide. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

Afamelanotide studies and clinical research

2026-04-03 PubMed

Unregulated Melanotan I & II use linked to altered moles and emerging melanoma, review finds

This review serves as a critical warning to individuals participating in the 'tanning culture' who may consider using unregulated melanotan peptides. **The key takeaway is that the cosmetic benefit of a tan may come w…

Research tools

Free, no account — handy when you're working with Afamelanotide.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$14 monthly or $88/year

Create an account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

Afamelanotide studies and clinical research

Unregulated Melanotan I & II use linked to altered moles and emerging melanoma, review finds

Research tools